Navigation Links
Takeda Responds to U.S. Food and Drug Administration Update to Safety Review of ACTOS (pioglitazone HCl)
Date:6/15/2011

DEERFIELD, Ill., June 15, 2011 /PRNewswire/ -- Following an announcement today from the U.S. Food and Drug Administration (FDA) regarding an update to its safety review of ACTOS, Takeda Pharmaceuticals North America, Inc. (Takeda) is confident in the therapeutic benefits of ACTOS and its importance as a treatment for type 2 diabetes. The company remains committed to ACTOS and ACTOS-containing medications, and to the millions of people living with the disease.

Takeda is dedicated to patient safety, and to ensuring that patients and physicians have accurate information regarding ACTOS. Takeda is committed to ongoing clinical research to understand and investigate potential safety concerns, and, working with appropriate regulatory agencies, is currently supporting a ten-year epidemiological study, started in 2002 by the University of Pennsylvania (U. of Penn.) and Kaiser Permanente Diabetes Registry, Northern California (KPNC), investigating the questions raised about ACTOS and bladder cancer. Takeda has been working with the FDA and European Medicines Agency (EMA) and has provided them with interim data from this study on a regular basis. Takeda is committed to supporting this study through its conclusion at the end of 2012 and will report on the final results upon completion.  

In the interim analysis of this epidemiologic data, published in Diabetes Care April 2011, the primary endpoint showed that treatment with ACTOS was not associated with a statistically significant increase in the incidence of bladder cancer. The investigators reported that "short-term use of pioglitazone was not associated with an increased incidence of bladder cancer, but use for more than two years was weakly associated with increased risk."  

Based on its recent data review, FDA has informed the public that "...use of the diabetes medication ACTOS (pioglitazone) for more than one year may be associated with an increased risk of bladder cancer." 
'/>"/>

SOURCE Takeda Pharmaceuticals North America, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Takeda to Acquire Nycomed
2. Amylin and Takeda Voluntarily Suspend Clinical Activities in Obesity Trial
3. Intra-Cellular Therapies and Takeda Enter into Worldwide Collaboration to Develop and Commercialize Compounds for Schizophrenia
4. Handa Pharmaceuticals Announces Submission of Its First-to-File ANDA for Takedas DEXILANT®
5. Takeda Submits New Drug Application in the U.S. for Azilsartan Medoxomil Plus Chlorthalidone, an Investigational Fixed-Dose Combination for the Treatment of Hypertension
6. Takeda Enters Into Global Strategic Partnerships With Covance and Quintiles
7. Takeda Completes Settlements With All Defendants in U.S. Patent Litigation Involving ACTOS® (pioglitazone HCI), ACTOplus met® (pioglitazone HCl and metformin HCl) and duetact® (pioglitazone HCl and glimepiride)
8. Takeda Responds to Announcement about Suspension of Rosiglitazone Marketing Authorization in Europe and Restrictions in the U.S.
9. Arthritis Foundation and Takeda Launch First-Ever National Gout Public Service Announcement (PSA) Campaign, Urging People Living With Gout to Keep Enjoying Lifes Simple Pleasures
10. Orexigen® Therapeutics and Takeda Enter Into Partnership to Commercialize Contrave® in North America
11. Takeda Responds to FDA Advisory Committee Recommendation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... 3, 2015 ReportsnReports.com adds ... with 2020 forecasts as well as Global Medical ... devices intelligence collection of its library. ... 2020 forecasts spread across 164 pages, talking about ... and figures is now available at http://www.reportsnreports.com/reports/407046-global-medical-simulation-industry-report-2015.html ...
(Date:8/3/2015)... , Aug. 3, 2015  Depomed, Inc. (NASDAQ: ... on Horizon Pharma plc,s (NASDAQ: HZNP ) ("Horizon") ... of Directors ("Depomed Board") set a record date to ... The Depomed Board will review the ... is received today and contains the information required under ...
(Date:8/3/2015)... , Aug. 3, 2015  Dr. Cal ... Orthopaedic & Spine Center today, providing patients ... their chronic pain through psychological counseling and treatment ... a Fellowship-trained, certified medical psychologist with an extensive ... vast experience ranges from assessment and treatment of ...
Breaking Medicine Technology:Medical Simulation Market to see 14% CAGR to 2019 2Medical Simulation Market to see 14% CAGR to 2019 3Medical Simulation Market to see 14% CAGR to 2019 4Medical Simulation Market to see 14% CAGR to 2019 5Medical Simulation Market to see 14% CAGR to 2019 6Depomed Comments on Horizon Pharma Announcement 2Depomed Comments on Horizon Pharma Announcement 3Depomed Comments on Horizon Pharma Announcement 4Depomed Comments on Horizon Pharma Announcement 5Depomed Comments on Horizon Pharma Announcement 6Orthopaedic & Spine Center Introduces New Pain Psychologist 2
... June 2, 2011 Craneware, Inc., the market ... new multi-year agreement today with Kingman Regional Medical ... AZ. Recognized as one of the nation,s five ... Center will add Craneware InSight Denials® to the ...
... 2011 Syndax Pharmaceuticals, a clinical-stage epigenetics oncology ... Patent and Trademark Office of Patent Application Serial ... B."   This follows the UK issuance which ... the extensive patent estate. The patent ...
Cached Medicine Technology:Kingman Adds Craneware Revenue Integrity Solution - InSight Denials® 2Kingman Adds Craneware Revenue Integrity Solution - InSight Denials® 3Kingman Adds Craneware Revenue Integrity Solution - InSight Denials® 4Syndax Pharmaceuticals Announces Issuance of US Patent for Entinostat 2Syndax Pharmaceuticals Announces Issuance of US Patent for Entinostat 3
(Date:8/4/2015)... ... August 04, 2015 , ... Isabel Healthcare and ... Symptom Checker available to all users of the KHIN personal health record, MyKSHealtheRecords.org. ... in an easy, intuitive method, provides access to material on possible conditions and ...
(Date:8/3/2015)... (PRWEB) , ... August 04, 2015 , ... While the pace of the economic recovery ... States has clearly been on a growth trajectory for the last six years. Unemployment has ... and is trending at a 3.5 percent growth rate in 2014, the U.S. stock market ...
(Date:8/3/2015)... TX (PRWEB) , ... August 04, 2015 , ... ... convenient and affordable online CE courses for rehabilitation professionals, HomeCEUConnection.com today announced extra ... professionals in Florida can now take advantage of big savings on Physical ...
(Date:8/3/2015)... ... ... Master offers the most affordable web design and SEO services for start up companies. ... their dollar. Every company that is starting out needs to be online in this ... does a start up need to be online, they need to physically be present and ...
(Date:8/3/2015)... , ... August 03, 2015 , ... Sutter Health’s California ... operating officer (COO) at CPMC. Hamila will start in her role effective immediately and ... , Kownacki has worked at CPMC and Sutter Health for about 15 years, including ...
Breaking Medicine News(10 mins):Health News:Isabel Healthcare Partners with the Kansas Health Information Network, Inc. to Deploy Isabel Symptom Checker within the MyKSHealth eRecord Personal Health Record 2Health News:Isabel Healthcare Partners with the Kansas Health Information Network, Inc. to Deploy Isabel Symptom Checker within the MyKSHealth eRecord Personal Health Record 3Health News:Newport Board group, an Advisory Firm Serving the Middle Market, Cautions Businesses on How to Survive the Coming Recession 2Health News:Newport Board group, an Advisory Firm Serving the Middle Market, Cautions Businesses on How to Survive the Coming Recession 3Health News:Newport Board group, an Advisory Firm Serving the Middle Market, Cautions Businesses on How to Survive the Coming Recession 4Health News:Elite Online CE Provider Offers Discounted Flexible Packages to Meet Florida Physical Therapy Continuing Education Requirements 2Health News:Web SEO Master, a division of SH Web Design & SH Web Commerce, Inc. begins offering Web Design and SEO Services for Start Up Companies located in Indianapolis, Indiana 2Health News:Web SEO Master, a division of SH Web Design & SH Web Commerce, Inc. begins offering Web Design and SEO Services for Start Up Companies located in Indianapolis, Indiana 3Health News:Hamila Kownacki, RN Appointed as New Chief Operating Officer at CPMC 2
... new study by specialists at the Johns Hopkins Children’s ... inner-city children with chronic asthma //gets enough medicine to ... reported in December's Pediatrics, are disturbing, the researchers say, ... 'rescue' drugs after an asthma attack strikes and to ...
... The American Dental association announced on the 9th of November, ... preparation of infant formulation. // ,The dentists are concerned ... might be disastrous as instead of protecting teeth it might ... lead to weakened bones and even bone cancer boys. ...
... and Improvement suggested that some patients should be cared for ... them in the hospital wards. ,The draft ... and Emergency (A&E) departments that leads to hospital admissions and ... admitted in hospital wards. ,Home treatments ...
... in a gene known as SOS1 account for many ... //disorder which occurs in one in 1,000-2,500 live births. ... learning disabilities, as well as heart problems and predisposition ... School-Partners Healthcare Center for Genetics and Genomics (HPCGG) and ...
... of dubious consolation, nineteen persons infected with AIDS will ... most moneyed lawsuit//. This money should provide some relief ... them are living in poverty. ,Fifteen persons were ... at a provincial hospital of northern China in 2004. ...
... programme has been working effectively and the same has ... UNAIDS has not informed the Government about any award ... prevention amongst the services. ,The incidence of ... 2005 was 0.028%. ,No disciplinary action is ...
Cached Medicine News:Health News:City Kids With Asthma Lose Out on Preventive Treatment 2Health News:Study Uncovers Mutation Responsible for Noonan Syndrome 2
The CA method used on the Dade Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of calcium in serum....
For the quantitative in vitro determination of Total Protein in serum and plasma...
The LDH method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of lactate dehydrogenase activity in serum or plasma...
For the quantitative in vitro determination of Anti-Streptolysin-O (ASO) in serum....
Medicine Products: